Why the study?
Does multivariate analysis of heart rate variability and clinical parameters improve risk stratification for mortality in patients with ischemic dilated cardiomyopathy?
Does multivariate analysis of heart rate variability and clinical parameters improve risk stratification for mortality in patients with ischemic dilated cardiomyopathy?
Combining HRV complexity measures with clinical parameters like left atrial size improves risk stratification for mortality in patients with ischemic dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
May improve mortality risk stratification in ischemic dilated cardiomyopathy; leaves open prospective validation before clinical adoption.
Valencia et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: